Vanta Bioscience Ltd Financial Ratios
VANTABIO · Healthcare · Current price ₹25.29
P/E ratio
168.6x
P/B ratio
0.8x
ROE
0.7%
ROCE
-11.6%
Debt / Equity
1.80
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 168.6x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 0.8x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 0.7% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -11.6% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 1.80 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Vanta Bioscience Ltd's latest numbers.
Vanta Bioscience Ltd profitability
Vanta Bioscience Ltd generates a return on equity of 0.7% and a return on capital employed of -11.6%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 1.80 and a P/E of 168.6x, Vanta Bioscience Ltd is carrying meaningful debt. Our overall business-quality score for the company is 3.1 / 10.
Understand the ratios
More on Vanta Bioscience Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.